A synthetic peptide for use as a blocking control in assays to test for specificity of NBL1 antibody, Alternative Names: NBL1 control peptide, NBL1 antibody Blocking Peptide, Anti-NBL1 Blocking Peptide, Neuroblastoma Suppression Of Tumorigenicity 1 Blocking Peptide, D1S1733E Blocking Peptide, DAN Blocking Peptide, DAND1 Blocking Peptide, MGC8972 Blocking Peptide, NB Blocking Peptide, NO3 Blocking Peptide, NBL1, NBL-1, NBL 1, NBL-1 Blocking Peptide, NBL 1 Blocking Peptide
Aufreinigung
The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
NBL1
(Neuroblastoma 1, DAN Family BMP Antagonist (NBL1))
Hintergrund
This gene product is the founding member of the evolutionarily conserved CAN (Cerberus and DAN) family of proteins, which contain a domain resembling the CTCK (C-terminal cystine knot-like) motif found in a number of signaling molecules.